BRAIDWELL LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001920938

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2025 · 71 positions · Total reported value $2.93B · Top-10 concentration 38.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.0% · 24 new · 32 cut · 25 exited

Active Share (vs S&P 500): 98.9% · vs QQQ: 99.4% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +24.0% · vs SPY +9.2% · Prev Value $2.64B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2025 13F filing, BRAIDWELL LP disclosed 71 equity positions with a combined reported value of $2.93B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 38.2% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2025 were CAI ($210.88M), GH ($192.31M), EWTX ($129.31M). By sector, the heaviest allocations are Health Care 80.9%, Technology 4.6%. Versus the prior quarter, allocation shifted toward Other (+0.9pp) and away from Health Care (-0.7pp), Industrials (-1.1pp).

Versus the prior quarter, BRAIDWELL LP opened 24 new positions, trimmed 32 and fully exited 25, a turnover rate of 75.0% of positions. The portfolio's overlap with the prior quarter was 58% of names.

The largest new positions opened in Q4 2025 were KOD ($57.96M), CNTA ($54.73M), BTSG ($44.78M).

Of the 25 positions fully exited versus the prior quarter, the largest were NVCR ($210.04M), GMED ($28.52M), THC ($24.71M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • KOD KODIAK SCIENCES INC · $57.96M
  • CNTA CENTESSA PHARMACEUTICALS PLC · $54.73M
  • BTSG BRIGHTSPRING HEALTH SVCS INC · $44.78M
  • NRIX NURIX THERAPEUTICS INC · $41.43M
  • ILMN ILLUMINA INC · $35.37M
  • MBX MBX BIOSCIENCES INC COM · $32.13M
  • RAPT RAPT THERAPEUTICS INC · $31.49M
  • NTRA NATERA INC · $25.54M

Fully Exited (vs previous quarter)

  • NVCR NOVOCURE LTD · prev qtr: $210.04M
  • GMED GLOBUS MED INC · prev qtr: $28.52M
  • THC TENET HEALTHCARE CORP · prev qtr: $24.71M
  • EXAS EXACT SCIENCES CORP · prev qtr: $22.68M
  • AKRO AKERO THERAPEUTICS INC · prev qtr: $22.57M
  • ATEC ALPHATEC HLDGS INC · prev qtr: $22.02M · history
  • VKTX VIKING THERAPEUTICS INC · prev qtr: $19.96M
  • RARE ULTRAGENYX PHARMACEUTICAL IN · prev qtr: $17.71M

Insider Transactions (Form 4)

Latest BRAIDWELL LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Braidwell LP, based in Stamford, CT, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 83 positions worth $2.54B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: STAMFORD, CT, United States
  • SEC registration: 801-122966 (status: Approved), registered 2022-01-03
  • Regulatory AUM (Form ADV): $3.63B as of 2026-09-22
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 12 private funds, of which 11 hedge funds
  • Website: braidwell.com

Portfolio Structure

  • 83 positions · $2.54B reported value (Q2 2026)
  • Top 10 holdings = 32.8% of reported value
  • Largest position: CAI (CARIS LIFE SCIENCES INC) at 5.8%
  • Average position size: $30.62M

Sector Tilt

  • Health Care 90.1%
  • Information Technology 4.3%
  • Industrials 4.3%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 24 new, 21 added, 32 reduced, 25 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 80.9%
Technology 4.6%
Other 10.5%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 7.82M $210.88M 7.21%
7.21%
Add
2 104.85M $192.31M 6.57%
6.57%
Reduce
3 5.21M $129.31M 4.42%
4.42%
Hold
4 751.53K $106.59M 3.64%
3.64%
Reduce
5 921.98K $104.10M 3.56%
3.56%
Add
6 821.41K $82.63M 2.82%
2.82%
Reduce
7 1.83M $81.80M 2.79%
2.79%
Reduce
8 1.87M $77.67M 2.65%
2.65%
Reduce
9 52.00M $72.80M 2.49%
2.49%
Reduce
10 1.30M $60.60M 2.07%
2.07%
Add
11 381.00K $59.49M 2.03%
2.03%
Reduce
12 2.07M $57.96M 1.98%
1.98%
New
13 1.19M $55.00M 1.88%
1.88%
Reduce
14 2.19M $54.73M 1.87%
1.87%
New
15 4.63M $54.48M 1.86%
1.86%
Add
16 2.03M $54.28M 1.85%
1.85%
Reduce
17 1.63M $53.55M 1.83%
1.83%
Reduce
18 1.27M $52.50M 1.79%
1.79%
Add
19 53.41M $50.47M 1.73%
1.73%
Reduce
20 1.86M $50.47M 1.72%
1.72%
Add
21 540.89K $49.89M 1.71%
1.71%
Reduce
22 202.10K $49.83M 1.70%
1.70%
Reduce
23 83.42K $47.24M 1.61%
1.61%
Reduce
24 80.72K $46.78M 1.60%
1.60%
Reduce
25 1.20M $44.78M 1.53%
1.53%
New
26 564.20K $44.77M 1.53%
1.53%
Add
27 575.07K $43.41M 1.48%
1.48%
Reduce
28 2.18M $41.43M 1.42%
1.42%
New
29 784.74K $39.74M 1.36%
1.36%
Add
30 217.34K $38.57M 1.32%
1.32%
Reduce
31 315.34K $38.36M 1.31%
1.31%
Reduce
32 601.52K $35.75M 1.22%
1.22%
Add
33 269.67K $35.37M 1.21%
1.21%
New
34 454.26K $35.35M 1.21%
1.21%
Add
35 3.06M $34.62M 1.18%
1.18%
Add
36 110.15K $34.25M 1.17%
1.17%
Reduce
37 1.02M $32.13M 1.10%
1.10%
New
38 929.69K $31.49M 1.08%
1.08%
New
39 1.59M $29.87M 1.02%
1.02%
Reduce
40 1.48M $28.92M 0.99%
0.99%
Reduce
41 3.13M $28.28M 0.97%
0.97%
Add
42 1.30M $28.22M 0.96%
0.96%
Reduce
43 8.35M $27.15M 0.93%
0.93%
Hold
44 118.23K $27.06M 0.93%
0.93%
Reduce
45 31.01K $26.08M 0.89%
0.89%
Reduce
46 111.50K $25.54M 0.87%
0.87%
New
47 324.36K $25.31M 0.86%
0.86%
Add
48 575.32K $23.24M 0.79%
0.79%
New
49 3.11M $20.65M 0.71%
0.71%
New
50 115.70K $20.36M 0.70%
0.70%
New

FAQ

What did BRAIDWELL LP buy in 2025-Q4?

In its 2025-Q4 13F filing, BRAIDWELL LP reported 71 equity positions worth $2.93B in aggregate; its largest disclosed positions were CAI ($210.88M), GH ($192.31M), EWTX ($129.31M).

How large is BRAIDWELL LP's portfolio?

BRAIDWELL LP reported $2.93B of long equity holdings across 71 positions as of 2025-Q4. Top-10 holdings account for 38.2% of reported value.

What is BRAIDWELL LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/braidwell/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →